Skip to Main Content

Paper Details

Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening.
bioRxiv
6
2020
3C like protease, 3CL pro, COVID-19, Hydroxocobalamin, LLL-12, M pro, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 3CL Protease, SARS-CoV-2 3CL pro, Suramin sodium, Walrycin B, Z, Z-DEVD-FMK, Z-FA-FMK, coronavirus disease, main protease, patients, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Min ShenNational Center for Advancing Translational Sciences, National Institutes of Health
Min ShenNational Center for Advancing Translational Sciences, National Institutes of Health
Sam MichaelNational Center for Advancing Translational Sciences, National Institutes of Health
  • 1 - 3

Datasets

Release 1.2